Viewing Study NCT02963168


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-02-04 @ 3:48 PM
Study NCT ID: NCT02963168
Status: UNKNOWN
Last Update Posted: 2019-10-17
First Post: 2016-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
Sponsor: Athenex, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module